Martin Vogelbaum's Net Worth
$453 Thousand
Who is Martin Vogelbaum?
Martin Vogelbaum does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ADVANCIS PHARMACEUTICAL CORP, Cara Therapeutics, Inc., INOTEK PHARMACEUTICALS CORP, NephroGenex, Inc., and NUVELO INC.
SEC CIK
Martin Vogelbaum's CIK is 0001237624
Past Insider Trading and Trends
2019 was Martin Vogelbaum's most active year for acquiring shares with 3 total transactions. Martin Vogelbaum's most active month to acquire stocks was the month of May. 2020 was Martin Vogelbaum's most active year for disposing of shares, totalling 1 transactions. Martin Vogelbaum's most active month to dispose stocks was the month of May. 2015 saw Martin Vogelbaum paying a total of $60,360.00 for 25,500 shares, this is the most they've acquired in one year. In 2021 Martin Vogelbaum cashed out on 8,640 shares for a total of $112,752.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADVANCIS PHARMACEUTICAL CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.3227
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +274.62% | 301.3K |
—
|
—
| 411.01K |
Jun 4
| |||
Form 4
| +143.87% | 64.72K |
—
|
—
| 109.71K |
Jun 1
| |||
Form 4
| -19.36% | -10.80K |
$10.28 | -$111,024.00 | 44.99K |
Sep 14
| |||
Form 4
| +176.73% | 35.63K |
—
|
—
| 55.79K |
Jun 2
| |||
Form 4
| +40.00% | 5.76K |
$13.05 | -$112,752.00 | 20.16K |
Scheduled
|
Jun 3 - Jun 7
| ||
Form 4
| -29.41% | -6.00K |
$16.09 | -$96,540.00 | 14.4K |
Nov 17
| |||
Form 4
| +240.00% | 14.4K |
—
|
—
| 20.4K |
Jun 4
| |||
Form 4/A
|
∞
| 6K |
—
|
—
| 6K |
Jun 4
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +14.99% | 400K |
$4.87 | $1,949,202.91 | 3.07M |
Mar 16 - Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
∞
| 2.67M |
$11.00 | $2,483,998.00 | 2.67M |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INOTEK PHARMACEUTICALS CORP (RCKT) Snapshot price: $18.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NephroGenex, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NUVELO INC (ABIO) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||